antimicrobial defensin peptides (Innova Proteomics/INSERM)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameantimicrobial defensin peptides (Innova Proteomics/INSERM)
Drug Alias Nameanti-infectious peptides (INSERM/Innova Proteomics)
ClassificationBiologics > Protein drugs > Recombinant polypeptideNatural product/Extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInserm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnova ProteomicsInserm
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A